80.3%

Your current location:HomeProductsIEsophagcomf

请输入文本内容

IEsophagcomf

Non-invasive early detection of esophageal cancer genes

A tube of blood to detect esophageal cancer

【Highly targeted】Special development based on the characteristics of high incidence of squamous cell carcinoma in Chinese

【Good experience】] Non-invasive sampling, free from the pain of endoscopy

Sensitivity 80.3%

Specificity 91.38%

Significance of early detection of esophageal cancer

'Chinese characteristics' of esophageal cancer: Squamous cell carcinoma is the most common pathological type of esophageal cancer in my country, accounting for more than 90% of the incidence of esophageal cancer.

China has the highest incidence and high mortality rate

The incidence and deaths of esophageal cancer in my country rank first in the world

Late detection and poor quality of life

More than 90% of patients with esophageal cancer have progressed to the middle and advanced stages at the time of diagnosis, with poor quality of life, and the overall 5-year survival rate is<20%

Proactive screening to improve survival

Early screening, early detection, less pain, low cost, and high quality of life, the 5-year survival rate of patients can be >95%.

Experts recommend: 'Beginning at the age of 40, those with related high-risk factors should undergo esophageal cancer screening every 1-3 years.'

Esophageal Cancer Detection Methodology

Detection principle

The occurrence of early tumors is often accompanied by specific DNA methylation abnormalities, and tumor suppressor gene silencing caused by methylation of tumor suppressor gene promoter regions is an early event in tumorigenesis;

During the process of apoptosis and necrosis of tumor cells, a large number of tumor DNA fragments will be released into peripheral blood, resulting in the abnormal DNA content in peripheral blood being much higher than that of healthy people;

By detecting abnormal methylation of tumor DNA fragments in plasma, the corresponding cancer can be detected.

先设置数据

Product advantages

Verified by clinical samples, the sensitivity is 80.3% and the specificity is 91.38%. Precancerous lesions are detected 5 years in advance, and the test results are safe and reliable.

Flexible selection of sampling methods (hospital/home), sampling in 1 minute, scanning code in 1 minute,Professional test, report issued within 7 working days